Incyte (INCY) Receivables - Net (2010 - 2026)
Incyte (INCY) reported Receivables - Net of $1.13 billion for Q2 2026, up 33.5% from $842.89 million a year earlier and up 7.0% from the prior quarter.
Powered by 
Analysis
Incyte (INCY) Receivables - Net (2010 - 2026) Analysis & Trends
At the end of FY2025, Incyte posted Receivables - Net of $1.02 billion, up 20.1% from FY2024.
- Receivables - Net has increased for 12 consecutive years, with a five-year compound annual growth rate of 16.3% (FY2020 to FY2025).
- By year, Receivables - Net came in at $853.15 million in FY2024 (+14.7%), $743.56 million in FY2023 (+15.3%), $644.88 million in FY2022 (+4.6%) and $616.3 million in FY2021 (+27.9%).
- The Q2 2026 figure ranks as the highest quarterly Receivables - Net in data going back to Q4 2010.
- Year over year, Receivables - Net has now increased in each of the last 12 quarters, with growth averaging 19.3% over the last eight quarters.
- The high point for year-over-year Receivables - Net in five years was Q2 2022 (growth of 55.9%); the low point was Q2 2023 (a decline of 6.6%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $1.05 billion (Q1 2026), $1.02 billion (Q4 2025) and $895.89 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn |
| 10 | Incyte | 25.09 Bn | 10.02 Bn | 1.57 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.13 Bn |
| Mar 31, 2026 | 1.05 Bn |
| Dec 31, 2025 | 1.02 Bn |
| Sep 30, 2025 | 895.89 Mn |
| Jun 30, 2025 | 842.89 Mn |
| Mar 31, 2025 | 823.13 Mn |
| Dec 31, 2024 | 853.15 Mn |
| Sep 30, 2024 | 758.45 Mn |
| Jun 30, 2024 | 739.05 Mn |
| Mar 31, 2024 | 745.53 Mn |
| Dec 31, 2023 | 743.56 Mn |
| Sep 30, 2023 | 657.26 Mn |
| Jun 30, 2023 | 637.99 Mn |
| Mar 31, 2023 | 623.79 Mn |
| Dec 31, 2022 | 644.88 Mn |
| Sep 30, 2022 | 618.19 Mn |
| Jun 30, 2022 | 682.97 Mn |
| Mar 31, 2022 | 562.34 Mn |
| Dec 31, 2021 | 616.30 Mn |
| Sep 30, 2021 | 516.69 Mn |
API Access
Incyte Receivables - Net API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables-net&ticker=INCY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables-net", "ticker": "INCY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables-net&ticker=INCY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();